Evidence map›Paper›PMID 34948472›Full record

ReviewInternational journal of molecular sciences2021

Ionic Regulation of T-Cell Function and Anti-Tumour Immunity.

Pierpaolo Ginefra, Helen Carrasco Hope, Mattia Spagna, Alessandra Zecchillo, Nicola Vannini

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Metallic nanomedicine in cancer immunotherapy.Acta pharmaceutica Sinica. B · 2025
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Pierpaolo GinefraDepartment of Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, 1066 Epalinges, Switzerland.ORCID 0000-0003-3254-1269
Helen Carrasco HopeDepartment of Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, 1066 Epalinges, Switzerland.ORCID 0000-0001-5583-4510
Mattia SpagnaDepartment of Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, 1066 Epalinges, Switzerland.
Alessandra ZecchilloDepartment of Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, 1066 Epalinges, Switzerland.
Nicola VanniniDepartment of Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, 1066 Epalinges, Switzerland.
Ludwig Cancer Research · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The capacity of T cells to identify and kill cancer cells has become a central pillar of immune-based cancer therapies. However, T cells are characterized by a dysfunctional state in most tumours. A major obstacle for proper T-cell function is the metabolic constraints posed by the tumour microenvironment (TME). In the TME, T cells compete with cancer cells for macronutrients (sugar, proteins, and lipid) and micronutrients (vitamins and minerals/ions). While the role of macronutrients in T-cell activation and function is well characterized, the contribution of micronutrients and especially ions in anti-tumour T-cell activities is still under investigation. Notably, ions are important for most of the signalling pathways regulating T-cell anti-tumour function. In this review, we discuss the role of six biologically relevant ions in T-cell function and in anti-tumour immunity, elucidating potential strategies to adopt to improve immunotherapy via modulation of ion metabolism.

Indexed as

Gene Expression Regulation, NeoplasticHumansIonsNeoplasmsSignal TransductionT-LymphocytesTumor MicroenvironmentIonsimmunomodulationionsnutrient competitionT celltumour microenvironment

Identifiers

PMID34948472
PMCPMC8705279
OpenAlexW4200553100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.